KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Zimmer Biomet Holdings (ZBH) Restructuring Costs (2016 - 2020)

Zimmer Biomet Holdings (ZBH) has 6 years of Restructuring Costs data on record, last reported at $8.1 million in Q4 2020.

  • For Q4 2020, Restructuring Costs rose 200.0% year-over-year to $8.1 million; the TTM value through Dec 2020 reached $23.8 million, up 310.34%, while the annual FY2020 figure was $23.8 million, 95.08% up from the prior year.
  • Restructuring Costs reached $8.1 million in Q4 2020 per ZBH's latest filing, down from $9.1 million in the prior quarter.
  • Across five years, Restructuring Costs topped out at $191.4 million in Q4 2016 and bottomed at -$14.4 million in Q4 2018.
  • Average Restructuring Costs over 5 years is $43.0 million, with a median of $27.2 million recorded in 2017.
  • Peak YoY movement for Restructuring Costs: tumbled 125.76% in 2018, then soared 450.0% in 2020.
  • A 5-year view of Restructuring Costs shows it stood at $191.4 million in 2016, then plummeted by 70.79% to $55.9 million in 2017, then crashed by 125.76% to -$14.4 million in 2018, then surged by 43.75% to -$8.1 million in 2019, then soared by 200.0% to $8.1 million in 2020.
  • Per Business Quant database, its latest 3 readings for Restructuring Costs were $8.1 million in Q4 2020, $9.1 million in Q3 2020, and $2.2 million in Q2 2020.